
Analysts have revised Hyundai’s one-year average price target down to ₩32,130 (an 11.27% cut from the prior ₩36,210 target dated Dec 3, 2025), with a latest analyst range of ₩30,300–₩34,650, implying ~42.48% upside versus the recent close of ₩22,550. The company yields 3.10% with a low payout ratio of 0.11, while institutional ownership fell 3.6% to 354K shares and the number of reporting funds declined by two to 20, indicating modest investor repositioning despite sizable implied upside.
Market structure: The analyst re-rating (avg PT ₩32,130 = +42% vs current ₩22,550) implies consensus expects material upside over 12 months; winners are Hyundai (KOSE:011760) equity holders and Korean auto suppliers if uplift occurs, losers are underweighted index allocations and short-term momentum bears. Pricing power vs peers should tighten if recovery in global auto demand and KRW weakness persist, supporting margin leverage; supply constraints (chips, freight) remain the main choke point. Risk assessment: Tail risks include a China demand shock, abrupt EV subsidy removals in key markets, or a large recall that could wipe >10-15% EPS in a year; regulatory or tariff moves are low-probability/high-impact within 6-12 months. Immediate (days) — limited reaction; short-term (weeks–months) — Q4 results, holiday shipment cadence and FX moves matter; long-term (quarters+)= EV transition, capex and R&D cadence. Trade implications: Direct play — tactical long KOSE:011760 sized 2-3% portfolio weight targeting ₩32,130 within 9–12 months, scale-in 25% now and add on 10–15% dips. Pair trade — go long KOSE:011760 vs short 000270.KS (Kia) 0.75x notional to express idiosyncratic re-rating; options — implement a 12-month bull-call spread (buy Dec-2026 ₩22,500 call, sell Dec-2026 ₩32,000 call) to cap capital and capture upside. Contrarian angles: Consensus underestimates the low payout ratio (0.11) as dry powder for buybacks/dividend increases — a catalyst that could compress supply and drive a re-rate if management signals capital return. Institutional selling (‑3.6% to 354K shares) looks like tactical rebalancing, not structural capitulation; mispricing exists if PTs hold and no negative catalyst appears within 6 months.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly positive
Sentiment Score
0.25